Assessing uMotif’s smartphone based Parkinson’s wellbeing tracker
1
Assessing uMotif’s smartphone based Parkinson’s wellbeing tracker Dr. Caspar Addyman*, 1 Bruce Hellman 2 and Dr. Jon Stamford 3 *Correspondence email [email protected] 3. Cure Parkinson’s Trust St Botolphs, Aldgate High Street London EC3N 1AB 1. Centre for Brain and Cognitive Development (CBCD), Birkbeck, University of London, Malet Street, London, WC1E 7HX, UK 2. uMotif Limited, UK www.uMotif.com [email protected] uMotif Digital Health Midlands and East Pre & post test questionnaires Cognitive Testing 1 2 3 4 5 START END Average Self Rating Suppleness scores 1 2 3 4 5 START END Average Self Rating Tremor scores 1 2 3 4 5 START END Average Self Rating Dyskinesia scores 1 2 3 4 5 START END Average Self Rating Bradykinesia scores Parkinson’s symptoms Limited App (N=14) Full App (N=15) † p<.1, * p<.05, ** p<.01,*** p<.005 Health Behaviours *** 1 2 3 4 5 START END Exercise 1 2 3 4 5 START END Water * 1 2 3 4 5 START END Average Self Rating Medication Well Being Measures 1 2 3 4 5 START END Energy ** 1 2 3 4 5 START END Sleep † 1 2 3 4 5 START END Average Self Rating Mood † Daily Self Report Data Background The current research evaluates a new smartphone app designed to help people with Parkinson’s Disease manage their medication & improve their health behaviours through self-tracking. The app also represents an interesting new research platform for in-situ testing of cognitive performance. Detailed daily tracking provides the potential to empower and motivate patients with long term conditions, encouraging them to engage positively with the management of their conditions while providing better data to healthcare professionals. Trial Summary • Users reported engagement with tracking and ease of use • App was used on average 38.5 out of 55 days (70%) • App provides rich new source of data on the daily effects of Parkinson’s Disease • Self-tracking leads to - Improved medication adherence – Improved health behaviours (water & exercise) – Improved well being (mood, sleep & energy) Next Steps • Successful second round NHS SBRI funding (June 2013 – June 2014) • Extensive further development of smartphone app and web portal • Randomised Control Trial (RCT) – 300 person, multi-centre trial across 6 NHS trusts in England and Scotland – 4 month trial period (Jan-May 2014) – Using Full app. vs. Treatment As Usual – Evaluation by Neurologists & PD nurses Design Web-based portal for Health Professionals Pre Trial Pre Trial Daily Self Report Medicine Reminders Tapping Test Numerical Stroop Partial 41 people with Parkinson’s initially recruited Questionnaires PDQ-39, Parkinson’s Non-Motor Symptoms (NMS), Quality of Life Score (QOLS), Morisky Medicines Adherence 6-8 Weeks 6-8 Weeks PARTIAL APP N = 14 FULL APP N = 15 Post Trial Post Trial Full Full Questionnaires N = 10 Questionnaires N = 6 Results
-
Upload
caspar-addyman -
Category
Health & Medicine
-
view
240 -
download
1
Transcript of Assessing uMotif’s smartphone based Parkinson’s wellbeing tracker
Assessing uMotif’s smartphone based Parkinson’s wellbeing tracker
Dr. Caspar Addyman*,1
Bruce Hellman2
and Dr. Jon Stamford3
*Correspondence [email protected]
3. Cure Parkinson’s TrustSt Botolphs, Aldgate High StreetLondonEC3N 1AB
1. Centre for Brain and Cognitive Development (CBCD), Birkbeck, University of London,Malet Street, London,WC1E 7HX, UK
2. uMotif Limited, [email protected]
Digital Health Midlands and East
Pre & post test questionnaires Cognitive Testing
1
2
3
4
5
START END Aver
age
Sel
f Rat
ing
Suppleness scores
1
2
3
4
5
START END Av
erag
e S
elf R
atin
g
Tremor scores
1
2
3
4
5
START END Aver
age
Sel
f Rat
ing
Dyskinesia scores
1
2
3
4
5
START END
Aver
age
Sel
f Rat
ing
Bradykinesia scores
Parkinson’s symptoms
Limited App (N=14) Full App (N=15) † p<.1, * p<.05, ** p<.01,*** p<.005
Health Behaviours
***
1
2
3
4
5
START END
Exercise
1
2
3
4
5
START END
Water
*
1
2
3
4
5
START END
Aver
age
Sel
f Rat
ing
Medication
Well Being Measures
1
2
3
4
5
START END
Energy
**
1
2
3
4
5
START END
Sleep
†
1
2
3
4
5
START END
Aver
age
Sel
f Rat
ing
Mood
†
Daily Self Report Data
BackgroundThe current research evaluates a new smartphone app designed to help people with Parkinson’s Disease manage their medication & improve their health behaviours through self-tracking. The app also represents an interesting new research platform for in-situ testing of cognitive performance. Detailed daily tracking provides the potential to empower and motivate patients with long term conditions, encouraging them to engage positively with the management of their conditions while providing better data to healthcare professionals.
Trial Summary• Users reported engagement with tracking and ease of use
• App was used on average 38.5 out of 55 days (70%)
• App provides rich new source of data on the daily effects of
Parkinson’s Disease
• Self-tracking leads to
- Improved medication adherence
– Improved health behaviours (water & exercise)
– Improved well being (mood, sleep & energy)
Next Steps• Successful second round NHS SBRI funding (June 2013 – June 2014)
• Extensive further development of smartphone app and web portal
• Randomised Control Trial (RCT)
– 300 person, multi-centre trial across 6 NHS
trusts in England and Scotland
– 4 month trial period (Jan-May 2014)
– Using Full app. vs. Treatment As Usual
– Evaluation by Neurologists & PD nurses
Design
Web-based portal for Health Professionals
Pre TrialPre Trial
Daily Self Report Medicine Reminders Tapping Test
Numerical Stroop
Partial
41 people with Parkinson’s initially recruited
Questionnaires PDQ-39, Parkinson’s Non-Motor Symptoms (NMS), Quality of Life Score (QOLS), Morisky Medicines Adherence
6-8Weeks
6-8Weeks
PARTIAL APP
N = 14FULL APP
N = 15
PostTrialPostTrial
FullFull
Questionnaires
N = 10Questionnaires
N = 6
Results
